PAPER Hassani OK, Rymar VV, Nguyen KQ, Huo L, Cloutier JF, Miller FD, Sadikot AF
PAPER Xiao B, He N, Wang Q, Cheng Z, Jiao Y, Haacke EM, Yan F, Shi F
Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease.Neuroimage Clin. 2019;24:102070. Epub 2019 Nov 5 PubMed: 31734535
PAPER Canas LS, Sudre CH, De Vita E, Nihat A, Mok TH, Slattery CF, Paterson RW, Foulkes AJ, Hyare H, Cardoso MJ, Thornton J, Schott JM, Barkhof F, Collinge J, Ourselin S, Mead S, Modat M
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.Neuroimage Clin. 2019;24:102051. Epub 2019 Oct 25 PubMed: 31734530
PAPER Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N31734228
PAPER Hoffman JL, Faccidomo S, Kim M, Taylor SM, Agoglia AE, May AM, Smith EN, Wong LC, Hodge CW
Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.Int Rev Neurobiol. 2019;148:169-230. Epub 2019 Oct 23 PubMed: 31733664
PAPER Henderson MX, Sengupta M, Trojanowski JQ, Lee VM31733655
PAPER Hassan R, Rabea AA, Ragae A, Sabry D
The prospective role of mesenchymal stem cells exosomes on circumvallate taste buds in induced Alzheimer's disease of ovariectomized albino rats: (Light and transmission electron microscopic study).Arch Oral Biol. 2020 Feb;110:104596. Epub 2019 Oct 31 PubMed: 31734542
PAPER Münster Y, Keyvani K, Herring A31734318
PAPER Giangrasso DM, Furlong TM, Keefe KA
Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.Neurobiol Dis. 2020 Feb;134:104673. Epub 2019 Nov 15 PubMed: 31734455
JOB 2019-11-18 Employer Rosalind Franklin University / The Chicago Medical School Principal Investigator Grace Stutzmann Contact email@example.com Description The Center for Neurodegenerative Disease and Therapeutics at the Rosalind Franklin ...
Blade Therapeutics, IncSouth San Francisco, United States
COMMENT This is an extraordinary study that provides a final piece of evidence for the causal involvement of microglia in Alzheimer’s disease. This work follows up a previous report from the same group, where the authors performed transcriptomic analysis of human ...
AstellasCambridge, United States
COMMENT The intriguing and encouraging results of the GV971 trial could be explained by an alternative—or perhaps additional—mechanism: the protective effect against AD might well be the consequence of the drug acting as an antiviral agent against HSV1, which has ...